Showing results (61-70 of 105) with videos related to
Sort By:
Pageof 11
Clinical Chemistry|January 12, 2017
Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial InfarctionAlma M A Mingels, Eline P M Cardinaels, Natascha J H Broers, et al.Respiratory Research|March 22, 2018
Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosisBart de Brouwer, Marjolein Drent, Jody M W van den Ouweland, et al.Nature Communications|December 1, 2025
Machine learning for risk stratification in the emergency department (MARS-ED): a randomized controlled trialPaul M E L van Dam, William P T M van Doorn, Lotte Sevenich, et al.Clinical Chemistry|December 13, 2016
Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial InfarctionAlexander S Streng, Douwe de Boer, William P T M van Doorn, et al.Blood Purification|March 27, 2004
Nitric oxide synthetic capacity in relation to dialysate temperatureCharles H Beerenhout, Marina Noris, Jeroen P Kooman, et al.The Journal of Applied Laboratory Medicine|February 27, 2021
Mass Spectrometric Identification of Cardiac Troponin T in Urine of Patients Suffering from Acute Myocardial InfarctionAlexander S Streng, Noreen van der Linden, Jordy M M Kocken, et al.European Journal of Clinical Pharmacology|August 23, 2007
Evaluation of limited sampling strategies for tacrolimusRobert A M Op den Buijsch, Afke van de Plas, Leo M L Stolk, et al.Toxicology|May 8, 2016
Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinomaLinda Rieswijk, Sandra M H Claessen, Otto Bekers, et al.BMJ Open Gastroenterology|November 30, 2024
Forns index and fatty liver index, but not FIB-4, are associated with indices of glycaemia, pre-diabetes and type 2 diabetes: analysis of The Maastricht StudyLeen Heyens, Hanna Kenjic, Pieter Dagnelie, et al.Fundamental & Clinical Pharmacology|July 20, 2007
Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphismsRobert A M Op den Buijsch, Maarten H L Christiaans, Leo M L Stolk, et al.Pageof 11